• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

New England Journal of Medicine

FDA warns against robot-assisted breast cancer surgeries

February 28, 2019 By Nancy Crotti

FDA has issued a warning against the use of surgical robots in mastectomies and other surgeries for the treatment or prevention of cancer. The safety and effectiveness of surgical robots have not been established for use in mastectomies or for surgeries to prevent or treat breast and other cancers, according to the agency, which said […]

Filed Under: Featured, Food & Drug Administration (FDA), News Well, Oncology, Regulatory/Compliance, Robotics, Surgical, Women's Health Tagged With: FDA, Intuitive Surgical, New England Journal of Medicine, northwellhealth

Medicare’s bundled ortho payments yield modest savings

January 2, 2019 By Nancy Crotti

Medicare’s randomized trial of a new bundled payment model for hip and knee replacement surgeries led to $812 in savings per procedure, a 3.1% reduction in costs when compared with traditional means of paying for care, according to new research. The study from Harvard T.H. Chan School of Public Health and Harvard Medical School found that the […]

Filed Under: Healthcare Reform, Hospital Care, Medicare, News Well, Orthopedics Tagged With: Centers for Medicare and Medicaid Services (CMS), Harvard Medical School, Harvard T.H. Chan School of Public Health, New England Journal of Medicine

St. Jude Medical’s HeartMate 3 implantable pump beats HeartMate II in pivotal trial

November 16, 2016 By Brad Perriello

The next-generation HeartMate 3 implantable pump St. Jude Medical (NYSE:STJ) acquired when it paid $3 billion for Thoratec last year proved superior to the older HeartMate II device at 6 months in pivotal clinical trial results released today. The Momentum 3 study enrolled more than 1,000 patients for a short-term outcome after 6 months and a longer-term, […]

Filed Under: Cardiovascular, Clinical Trials, Structural Heart Tagged With: American Heart Assn., New England Journal of Medicine, stjudemedical, Thoratec Corp.

Study finds high rate of overdiagnosis from mammograms

October 13, 2016 By MassDevice

(Reuters) – Better treatment and not earlier detection with screening mammography may be the reason rates of death from breast cancer have declined in recent years, according to controversial results from a large U.S. database study. In addition, the research team reports in The New England Journal of Medicine, “women were more likely to have […]

Filed Under: Diagnostics, Women's Health Tagged With: New England Journal of Medicine

Amid public feuds, NEJM finds itself under attack

April 6, 2016 By MassDevice

by Charles Ornstein, ProPublica. The New England Journal of Medicine is arguably the best-known and most venerated medical journal in the world. Studies featured in its pages are cited more often, on average, than those of any of its peers. And the careers of young researchers can take off if their work is deemed worthy […]

Filed Under: Business/Financial News, Clinical Trials, Research & Development Tagged With: New England Journal of Medicine

Medical journals propose mandatory data sharing

January 20, 2016 By Brad Perriello

Editors of some of the most prominent medical journals – including the New England Journal of Medicine, the Journal of the American Medical Assn., the Annals of Interal Medicine and the British Medical Journal – are proposing to require researchers to share the data behind their published studies. “[T]here is an ethical obligation to responsibly share data […]

Filed Under: Big Data, Clinical Trials Tagged With: Annals of Internal Medicine, British Medical Journal, International Committee of Medical Journal Editors, Journal of the American Medical Assn. (JAMA), New England Journal of Medicine

Medtronic sponsors Harvard Business School, NEJM value-based healthcare brain trust

October 12, 2015 By Fink Densford

Medtronic (NYSE:MDT) said today it is exclusively sponsoring the Insight Center, a collaborative program between the Harvard Business Journal and the New England Journal of Medicine focusing on value-based healthcare. The Insight Center aims to provide an online forum for leaders in policy, medicine and academia, Medtronic said. This year’s theme for the center is “Measuring […]

Filed Under: Business/Financial News, Healthcare Reform Tagged With: Medtronic, New England Journal of Medicine

Study: Artificial pancreas outperforms pump therapy

September 18, 2015 By Fink Densford

Data from 2 new studies of closed-loop artificial pancreas indicates the device outperformed sensor-augmented pump therapy treatment for patients with Type 1 diabetes. The findings were presented September 17 at the European Association for the Study of Diabetes 2015 meeting in Stockholm, Sweden, and published in the New England Journal of Medicine. After 12-weeks being […]

Filed Under: Clinical Trials, Diabetes Tagged With: New England Journal of Medicine

Bard touts publication of Lutonix study in NEJM

June 29, 2015 By Fink Densford

C.R. Bard (NYSE:BCR) said last Thursday that a 2-year study of its Lutonix drug-coated balloon catheter was published in The New England Journal of Medicine. The 2-year Levant 2 study data showed non-inferiority of the device and a trend towards superiority, compared to standard percutaneous transluminal angioplasty, in the treatment of peripheral artery disease, the company said. “We want to thank […]

Filed Under: Catheters, Clinical Trials, Vascular Tagged With: C.R. Bard, New England Journal of Medicine

Study: Overweight diabetics outlive slimmer patients

May 5, 2015 By MassDevice Leave a Comment

Study: Overweight diabetics outlive slimmer patients

(Reuters) — Patients with Type II diabetes who are overweight but not obese outlive diabetics of normal weight, scientists reported yesterday, in another example of the "obesity paradox."

Filed Under: News Well Tagged With: Annals of Internal Medicine, Clinical Trials, New England Journal of Medicine, University of Hull

More good news for stent thrombectomy

April 17, 2015 By Brad Perriello Leave a Comment

More good news for stent thrombectomy

A pair of clinical trials comparing treatment with anti-stroke drugs and stent thrombectomy with drug therapy alone showed reduced disability in stoke patients, bringing more good news for stent thrombectomy device makers.

Filed Under: News Well Tagged With: Clinical Trials, New England Journal of Medicine, Stroke

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS